Heaney Christopher, Tindall Genevieve, Lucas Joe, Haga Susanne B
Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina 27708, USA.
Genet Test Mol Biomarkers. 2010 Dec;14(6):821-7. doi: 10.1089/gtmb.2010.0066. Epub 2010 Oct 12.
BACKGROUND/AIMS: as genetic and genomic research proliferates, debate has ensued about returning results to participants. In addition to consideration of the benefits and harms to participants, researchers must also consider the logistical and financial feasibility of returning research results. However, little data exist of actual researcher practices.
we conducted an online survey of 446 corresponding authors of genetic/genomic studies conducted in the United States and published in 2006-2007 to assess the frequency with which they considered, offered to, or actually returned research results, what factors influenced these decisions, and the method of communicating results.
the response rate was 24% (105/446). Fifty-four percent of respondents considered the issue of returning research results to participants, 28% offered to return individual research results, and 24% actually returned individual research results. Of those who considered the issue of returning research results during the study planning phase, the most common factors considered were whether research results were deemed clinically useful (18%) and respect for participants (13%). Researchers who had a medical degree and conducted studies on children were significantly more likely to offer to return or actually return individual results compared to those with a Ph.D. only.
we speculate that issues associated with clinical validity and respect for participants dominated concerns of time and expense given the prominent and continuing ethical debates surrounding genetics and genomics research. The substantial number of researchers who did not consider returning research results suggests that researchers and institutional review boards need to devote more attention to a topic about which research participants are interested.
背景/目的:随着基因和基因组研究的不断增多,关于向参与者反馈研究结果的讨论随之而来。除了要考虑对参与者的利弊之外,研究人员还必须考虑反馈研究结果在后勤和经济方面的可行性。然而,关于研究人员实际做法的数据却很少。
我们对2006 - 2007年在美国开展并发表的446项基因/基因组研究的通讯作者进行了一项在线调查,以评估他们考虑、主动提出或实际反馈研究结果的频率,哪些因素影响了这些决定,以及反馈结果的方式。
回复率为24%(105/446)。54%的受访者考虑过向参与者反馈研究结果的问题,28%主动提出反馈个人研究结果,24%实际反馈了个人研究结果。在研究计划阶段考虑过反馈研究结果问题的人中,最常考虑的因素是研究结果是否被认为具有临床实用性(18%)和对参与者的尊重(13%)。与仅有博士学位的研究人员相比,拥有医学学位且对儿童进行研究的人员更有可能主动提出反馈或实际反馈个人结果。
鉴于围绕遗传学和基因组研究的突出且持续的伦理辩论,我们推测与临床有效性和对参与者的尊重相关的问题主导了对时间和费用的担忧。大量未考虑反馈研究结果的研究人员表明,研究人员和机构审查委员会需要更多地关注研究参与者感兴趣的这个话题。